Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Moreover, HAVN Life will receive one common share of Amalco for each common share of HAVN Subco held by HAVN Life.Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc.
生物技术公司HAVN生命科学公司。(CSE：HAVN)(场外交易：HAVLF)为采购功能性蘑菇保健品牌孢子生命科学公司。
The Deal Details
交易详情
Under the deal between HAVN Life, its newly incorporated, wholly-owned subsidiary, 1000053494 Ontario Inc. and Spore, HAVN Subco and Spore agreed to merge and continue as one corporation.
在.之下HAVN Life和HAVN Life之间的交易它是新成立的，全资子公司安大略省1000053494公司和孢子公司、HAVN Subco和孢子公司同意合并，并作为一个公司继续存在。
The holders of common shares of Spore will receive an aggregate of 95 million common shares of the HAVN Life for the Spore Shares issued and outstanding prior to closing.
这个孢子公司普通股的持有者将获得总计9500万股HAVN Life的普通股对于在收盘前已发行和已发行的孢子股票。
Moreover, HAVN Life will receive one common share of Amalco for each common share of HAVN Subco held by HAVN Life.
此外，HAVN Life每持有一股HAVN Subco普通股，将获得一股Amalco普通股。
In addition, in consideration of the issuance of the HAVN shares, Amalco agreed to issue to HAVN Life one Amalco share for each HAVN share issued.
此外，考虑到HAVN股票的发行，Amalco同意以每发行一股HAVN股票的方式向HAVN Life发行一股Amalco股票。
HAVN Life agreed to issue up to $11 million worth of common shares to the former shareholders of Spore and up to $19 million worth of common shares to certain consultants that will join HAVN Life upon completion of the deal upon achieving several milestones.
哈文人寿同意发行价值高达1100万美元的普通股给孢子公司的前股东，最高可达向将加入HAVN Life的某些顾问提供价值1900万美元的普通股在实现几个里程碑的情况下完成交易。
What It Means For Havn Life
这对Havn Life意味着什么
HAVN Life CEO Tim Moore said the deal is set to strengthen the company's position as "a leader in brain health-focused nutritional supplements."
哈文人寿首席执行官蒂姆·摩尔他说，这笔交易将巩固该公司作为“专注于大脑健康的营养补充剂的领导者”的地位。
Toronto-based Spore Life Sciences Inc. is a wellness brand focused on functional mushroom formulations.
总部位于多伦多的孢子生命科学公司是一家专注于功能性蘑菇配方的健康品牌。
Co-founded by CEO and president Michael Zavet, Spore boasts a significant U.S. consumer base of more than 110,000 customers, nearly 40,000 subscribers, resulting in year-to-date revenues as of the end of November 2021 of nearly CAD$8 million and current sales of more than $1 million per month.
由孢子公司首席执行官兼总裁迈克尔·扎维特该公司在美国拥有超过11万客户和近4万订户的庞大消费者基础，截至2021年11月底，今年迄今的收入接近800万加元，目前每月销售额超过100万美元。
What's Next?
下一个是什么？
Zavet said Spore is "excited to support HAVN's psychedelic endeavors through our digital marketing channels and large customer base."
扎维特说，孢子“很高兴能通过我们的数字营销渠道和庞大的客户基础支持HAVN的迷幻努力。”
The completion of the acquisition will bring in nine additional formulations under the HAVN Life retail brand, adding to its growing selection of natural health products that support overall health and cognitive function.
收购完成后，在HAVN Life零售品牌下增加了九种配方，增加了其越来越多的天然保健品选择，支持整体健康和认知功能。
HAVLF Price Action
HAVLF价格行动
HAVN Life Sciences' shares traded 11.73% higher at $0.14 per share at the time of writing on Monday morning.
拥有“生命科学”(HAvn Life Science)股价上涨11.73%，至每股0.14美元。在我写这篇文章的时候，是在周一早上。
Photo: Courtesy of Mari-Liis Link on Unsplash
图片：Unspash上的Mari-Liis Link提供
